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Risk Factors of Gastric Premalignant Lesion in Gastritis Patients
(Faktor Risiko Lesi Gastrik Premalignan pada Pesakit Gastritis)
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ABSTRACT
Gastric cancer is the second leading cause of cancer-related mortality and the fourth most common cancer globally. 
Gastric premalignant lesions are well known risk factors for the development of gastric cancer. The purpose of this 
study was to investigate the risk factors of gastric premalignant lesion. This cross-sectional study observed gastritis 
patients at Adam Malik General Hospital, Permata Bunda General Hospital, Universitas Sumatera Utara Hospital, all 
located in Medan, Indonesia. A total of 120 gastritis patients were included in this study. Patients were interviewed with 
a questionnaire to obtain demographic data, alcohol intake, smoking status, high salt diet and NSAID use. Diagnosis of 
Helicobacter pylori infection was made using positive results of the carbon-14 urea breath test (14C-UBT), rapid urease 
test, and/or immunohistochemistry. Endoscopy and biopsy were conducted to diagnose gastric premalignant lesion. 
Gastric premalignant lesion diagnosis was made when one or more of the following were present: Chronic atrophic 
gastritis, intestinal metaplasia, or dysplasia. Data were analysed using SPSS version 22. There were 35/120 (29.2%) of 
gastritis patients having gastric premalignant lesion. Multivariate analysis has shown that H. pylori infection, patients 
with family history of gastric cancer, alcohol consumption and Batak ethnic have increased risk to develop gastric 
premalignant lesion (p<0.05). All these results implied that risk factors of gastric premalignant lesion were H. pylori 
infection, family history of gastric cancer, alcohol intake and Batak ethnic. 
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ABSTRAK
Kanser gastrik merupakan penyebab kedua terbesar dalam kejadian kematian berkaitan dengan kanser dan berada di 
tempat keempat dalam kejadian kanser yang paling sering terjadi di seluruh dunia. Faktor risiko yang terkenal dalam 
perkembangan kanser gastrik adalah lesi gastrik premalignan. Objektif penyelidikan ini adalah untuk mengkaji faktor 
risiko kejadian lesi gastrik premalignan. Kajian keratan rentas ini dilakukan pada pesakit gastritis di hospital yang 
berlokasi di Medan, Indonesia seperti Hospital Umum Adam Malik, Hospital Umum Permata Bunda dan Hospital 
Universiti Sumatera Utara. Jumlah pesakit gastriris yang terlibat dalam penyelidikan ini adalah seramai 120 orang. 
Pesakit ditemu duga dengan soal selidik yang merangkumi pertanyaan mengenai data demografi,  pengunaan alkohol, 
status penghisapan rokok, diet yang mengandungi garam tinggi serta penggunaan ubat NSAID. Diagnosis pada infeksi 
Helicobacter pylori ditentukan daripada hasil positif pada ujian karbon-14 pernafasan urea (14C-UBT), ujian pantas 
urease dan/atau immunohistokimia. Endoskopi dan biopsi dijalankan untuk  pendiagnosisan lesi gastrik premalignan. 
Diagnosis lesi gastrik premalignan dilakukan sekiranya salah satu daripada lesi ini ditemui: Gastritis atrofik kronik 
dan/atau metaplasia atau displasia usus. Data dianalisis dengan menggunakan SPSS versi 22. 35 daripada 120 (29.2%) 
pesakit gastritis mempunyai lesi gastrik premalignan. Analisis secara multivariat menunjukkan bahawa infeksi H. pylori, 
pesakit dengan sejarah keluarga kanser gastrik, penggunaan alkohol serta etnik Batak didapati meningkatkan risiko 
perkembangan lesi gastrik premalignan (p<0.05). Kesimpulannya, keputusan kajian menunjukkan bahawa faktor risiko 
terjadinya lesi gastrik premalignan adalah infeksi H. pylori, pesakit dengan sejarah keluarga kanser gastrik, penggunaan 
alkohol dan etnik Batak.
Kata kunci: Faktor risiko; Helicobacter pylori; kanser gastrik; lesi gastrik premalignan
INTRODUCTION
Gastric cancer is the second leading cause of cancer-related 
mortality and the fourth most common cancer globally. 
Significantly more gastric cancer cases were noted in less 
developed regions compared to more developed regions 
(Ang & Fock 2014; Ferlay et al. 2008; Karim-Kos et 
al. 2008). Although the incidence of gastric cancer is 
declining, it still remains a major health problem and a 
common cause of cancer mortality worldwide (Rahman 
et al. 2014; Zali et al. 2011).
 Gastric carcinogenesis is a multistep and multifactorial 
process (Hu et al. 2012; Ishaq & Nunn 2015). Risk factors 
of gastric cancer are Helicobacter pylori infection, salt 
intake, smoking, alcohol, family history of gastric cancer 
and presence of gastric premalignant lesion such as 
atrophic gastritis, intestinal metaplasia and dysplasia. 
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Gastric premalignant lesions are well known risk factors 
for the development of gastric cancer (Almouradi et al. 
2013; Crew et al. 2016; De Vries et al. 2008; Lage et al. 
2016; Park & Kim 2015; Song et al. 2015; Yeh et al. 2009; 
Zhang et al. 2017; Zullo et al. 2012).
 However, since symptoms are most frequently absent 
in patients with gastric premalignant lesion, epidemiology 
of these lesion is largely unknown, especially in regions 
with a relatively low incidence of gastric cancer (Cheung 
2017; Weck & Brenner 2006). Identification and 
surveillance of patients with gastric premalignant lesion 
may lead to prevention of gastric cancer. Detection of 
gastric premalignant lesions is critical because they predict 
risk of malignant transformation, may assist in timely 
diagnosis of gastric cancer and consequently a better 
prognosis (De Vries et al. 2007; Yashima et al. 2010).
 Therefore, it is very important to investigate the risk 
factors of gastric premalignant lesion. By eliminating these 
risk factors, the incidence of gastric premalignant lesion 
would be lowered, so that gastric cancer eventually may 
be decreased.
MATERIALS AND METHODS
PATIENT SELECTION
This study was a cross-sectional study on 120 consecutive 
gastritis patients that were admitted to Endoscopy Units 
at Adam Malik General Hospital, Permata Bunda General 
Hospital, Universitas Sumatera Utara Hospital, Medan, 
Indonesia between October and December 2017. Inclusion 
criteria were patients diagnosed with gastritis from 
histopathology, age > 18 years, cooperative and willing to 
participate. Exclusion criteria included patients who have 
received H. pylori eradication therapy in the last 6 months 
or are currently on antibiotic therapy commonly used in 
eradication, pregnancy, suspected gastric malignancy, prior 
gastric surgery, concomitant use of proton pump inhibitors 
or H2 antagonists receptor. Written informed consent 
was obtained from all participants and the study protocol 
was approved by the clinical research ethics committee 
of Universitas Sumatera Utara. All participants were 
interviewed on their medical and family histories, followed 
by a brief physical examination. A structured questionnaire 
elicited informative on demographic data, alcohol intake, 
smoking status, high salt diet and NSAID use.
DIAGNOSIS OF GASTRIC PREMALIGNANT LESION
Tissue biopsy was performed within the greater and 
lesser curvature of the distal antrum, lesser curvature 
at incisura angularis, anterior and posterior wall of 
proximal corpus. Additional biopsies were also done in 
suspicious regions that were not mentioned previously. 
Microscopic observations were performed to diagnose 
gastric premalignant lesion (chronic atrophic gastritis, 
intestinal metaplasia and dysplasia) (Figure 1). One or 
a combination of these three disorders is called a gastric 
premalignant lesion. Histopathologic examination was 
done by 2 Pathologists at Universitas Sumatera Utara 
blindly. If there were differences in the results of the 
examination of both experts, then a third Pathologist to 
perform histopathological examination was required. 
H. PYLORI DETECTION
Diagnosis of H. pylori based on the positive results of 
carbon-14 urea breath test (14C-UBT), rapid urease test and/ 
or immunohistochemistry. Prior to 14C-UBT, patients had 
fasting for at least 6 h, usually overnight. Then, patients 
swallowed 37 kBq (1 μCi) of encapsulated 14C urea/
citric acid composition with 25 mL water. Breath samples 
of patients were collected into Heliprobe Breath Cards 
(Noster system) within 10 min after administration of the 
14C urea. Then patients exhaled onto the breath card until its 
colour indicator changed from orange to yellow. The breath 
samples were measured using the Heliprobe analyzer in 
 1A 1B 1C
FIGURE 1. Gastric premalignant lesions (A) Atrophy gastritis characterized by loss of gastric glands. (B) Intestinal 
metaplasia: the gastric epithelium is replaced by intestinal type of epithelium. The intestinal epithelium has goblet cells. 
(C) Dysplasia: cellular atypia, abnormal differentiation, and dysorganized architecture
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the period of 250 s. The results were expressed as counts 
per minute (cpm) with the reference values as follow. If 
the counts return to the value of < 25 cpm, then the result 
were defined as Heliprobe 0 (not infected). If the counts 
were between 25 and 50 cpm, this is defined as Heliprobe 
1 (equivocal) and counts > 25 cpm is defined as Heliprobe 
2 (infected) (Den Hoed et al. 2011).
 The rapid urease test (Pronto Dry®, France) was 
used to establish the diagnosis of H. pylori infection. 
The results were read within 24 h. The yellow colour 
indicated a negative result. A positive result was reported 
if the colour changed from amber to pink-red within 24 
h of incubation at room temperature (Rojborwonwitaya 
et al. 2005).
 Immunohistochemical (IHC) staining for evaluation 
of H. pylori status carried-out with procedure as follows. 
Tissue sections were deparaffinized, rehydrated and 
pretreated with Proteinase K for 8 min and incubated 
with ChemMate Peroxidase Blocking Solution in room 
temperature for 10 min. The slides were subsequently 
incubated with the polyclonal rabbit anti- H. pylori 
primary antibody (B0471: Dako Corporation, Glostrup, 
Denmark) with a dilution of 1:50 was conducted at room 
temperature for 1 h. After samples had been washed 3 
times with phosphate-buffered saline, the Dako EnVision 
Dual Link System–HRP (K4065: Dako Corporation) was 
applied for 30 min. Finally, sections were incubated in 
diaminobenzidine for 10 min, followed by hematoxylin 
counterstaining and mounting. H. pylori infected gastric 
mucosa from chronic gastritis patients served as positive 
controls. Negative controls were obtained by replacing 
the primary antibody with phosphate-buffered saline. H. 
pylori infection in the tissue sections was confirmed when 
short, curved or spiral bacilli resting on the epithelial 
surface, in the mucus layer, or deep in the gastric pits 
can be observed by light microscopy (Figure 2).
RESULTS AND DISCUSSION
CHARACTERISTICS OF SUBJECTS
Amongst the 120 patients, 54.2% were male with a median 
age of 49 years. The largest ethnic group was Batak 
(55.8%). There were 61.7% of patients infected with H. 
pylori. About 13.3% of patients consumed alcohol, 45% 
smoked, 15% of patients with high salt intake and 11.7% 
with concomitant use of NSAID.
PREVALENCE OF GASTRIC PREMALIGNANT LESION
A total of 29.2% of gastritis patients had chronic 
atrophic gastritis, 25.8% intestinal metaplasia and 3.3% 
dysplasia. Most patients had overlapping lesions. One or 
a combination of these three disorders is called a gastric 
premalignant lesion. There were 29.2% (35 patients) of 
gastritis patients with gastric premalignant lesion (Table 1).
These results vary greatly compared to previous studies. 
Den Hoed et al. (2011) in the Netherlands, De Vries et 
al. (2007) in the Netherlands, Roman et al. (2016) in St 
Petersburg found the prevalence of gastric premalignant 
lesion were 9.3%, 14%, 10.8%, respectively. While Haziri 
et al. (2010) in Kosova reported a high prevalence of gastric 
premalignant lesion in H. pylori infection, atrophic gastritis 
in 66%, intestinal metaplasia in 71.7%, dysplasia in 71.4%. 
Bedoya et al. (2012) in Colombia reported a prevalence of 
chronic atrophic gastritis in H. pylori infection of 38.5%, 
24.5% intestinal metaplasia and 1.6% dysplasia. Maran et 
al. (2013) reported that ethnic differences influenced the 
risk of gastric premalignant lesion, due to genetic variation. 
In addition, rates of H. pylori infection and diets such as 
smoked and salted foods, meat, alcohol consumption vary 
between countries.
FIGURE 2. H. pylori in the gaster tissues by 
immunohistochemistry (IHC)
STATISTICAL METHODS
Data analysis was performed using the SPSS 22 version 
(SPSS Inc., Chicago) with a 95% confidence interval. 
Analysis was performed using chi square test and binary 
logistic regression with significance p<0.05.
TABLE 1. Prevalence of gastric premalignant lesion
Diagnosis Present (%) 
Gastritis with gastric premalignant lesion (one 
or combination of chronic atrophic gastritis, 
intestinal metaplasia, and dysplasia)
35 (29.2)
Gastritis without gastric premalignant lesion 85 (70.8)
ASSOCIATION BETWEEN DEMOGRAPHIC 
CHARACTERISTICS, OVERWEIGHT, LIFESTYLE, FAMILY 
HISTORY OF GASTRIC CANCER, H. PYLORI INFECTION WITH 
GASTRIC PREMALIGNANT LESION
There were significant associations between age, Batak 
ethnic, alcohol intake, H. pylori infection, family history 
of gastric cancer with gastric premalignant lesion (Table 2). 
From results of multivariate analysis, H. pylori infection 
was most associated with gastric premalignant lesion, 
followed by family history of gastric cancer, alcohol intake 
and Batak ethnic (Table 3).
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TABLE 2. Association between demographic characteristics, overweight, lifestyle, family history 
of gastric cancer, H. pylori infection with gastric premalignant lesion
Variable
Gastric premalignant lesion Total p PR (95% CI)Yes No
Gender
 Male
  Female
23 (35.4%)
12 (21.8%)
42 (64.6%)
43 (78.2%)
65 (100%)
55 (100%)
0.103 1.62 (0.89-2.95)
 Age
  >49years
  <49 years
24 (38.1%)
11 (19.3%)
39 (61.9%)
46 (80.7%)
63 (100%)
57 (100%)
0.024* 1.97 (1.07-3.66)
Education
  Low level
  High level
9 (45%)
26 (26%)
11 (55%)
74 (74%)
20 (100%)
100 (100%)
0.088 1.73 (0.96-3.11)
Ethnic
  Batak
  Non-Batak
25 (37.3%)
10 (18.9%)
42 (62.7%)
43 (81.1%)
67 (100%)
53 (100%)
0.027* 1.98 (1.04-3.75)
Overweight
  Yes
  No
12 (22.2%)
23 (34.8%)
42(77.8%)
43 (65.2%)
54 (100%)
66 (100%)
0.130 0.64 (0.35-1.16)
Alcohol intake
 Present 
 Absent
9 (56.3%)
26 (25%)
7 (43.8%)
78 (75%)
16 (100%)
104 (100%)
0.017* 2.25 (1.3-3.88)
Smoking status
  Present
  Absent
11 (20.4%)
24 (36.4%)
43 (79.6%)
42 (63.6%)
54 (100%)
66 (100%)
0.055 0.56 (0.3-1.04)
H. pylori
  Positive
  Negative
31 (41.9%)
4 (8.7%)
43 (58.1%)
42 (91.3%)
74 (100%)
46 (100%)
<0.001* 4.82 (1.82-12.76)
Family history of gastric cancer
  Present
  Absent
High salt diet
  Present
  Absent
NSAID use
  Present
  Absent
5 (83.3%)
30 (26.3%)
5 (27.8%)
30 (29.4%)
7 (50%)
28 (26.4%)
1 (16.7%)
84 (73.7%)
13 (72.2%)
72 (70.6%)
7 (50%)
78 (73.6%)
6 (100%)
114 (100%)
18 (100%)
102 (100%)
14 (100%)
106 (100%)
0.008*
0.888
0.113
3.17 (1.98-5.08)
0.94 (0.42-2.11)
1.89 (1.02-3.49)
*p<0.05
 TABLE 3. Multivariate analysis of factors associated with gastric premalignant lesion
Variable p PR (95% CI)
H. pylori infection
Family history of gastric cancer
Alcohol intake
Batak ethnic
Age > 49 years
0.003*
0.016*
0.034*
0.042*
0.440
4.63 (1.81-11.73)
3.02 (1.81-4.97)
1.94 (1.27-3.75)
1.69 (1.02-3.49)
1.45 (0.68-2.31)
*p<0.05
 Although from previous study, males more susceptible 
to have gastric cancer than female, probably due to 
smoking and alcohol consumption (Karimi et al. 2014), 
however, in this study, no significant associations were 
found between gender and gastric premalignant lesion 
(p>0.05). This result is supported by previous studies. 
Den Hoed et al. (2011) in the Netherlands, Benberin 
et al. (2013) in Kazakhstan and Mansour-Ghanaei et 
al. (2013) in Iran have found no significant association 
between gender and gastric premalignant lesion. Liu et al. 
(2010) and Malik et al. (2017) reported that more males 
had gastric premalignant lesion than females, but did not 
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differ significantly. This study found that all patients with 
dysplasia were males. Although there was no difference 
in the percentage of male and female in the overall gastric 
premalignant lesion, none of the females experienced 
dysplasia, presumably hormonal factors play a role here. 
Previous studies found that men are at higher risk of 
developing gastric cancers. Zhou et al. (2013) reported that 
estrogen hormones are protective against gastric cancer. 
Overexpression of estrogen receptor can decrease motility 
and invasion of cancer cells by inhibiting cell growth and 
malignant progression.
 A multicenter prospective study in Korea reported that 
age> 61 years was a risk factor for atrophic gastritis and 
intestinal metaplasia (Kim et al. 2008). Patients with gastric 
premalignant lesion were associated with older age than 
control group (mean age 60 years vs. 52.5 years, p<0.01) 
(Den Hoed et al. 2011). Benberin et al. (2013) also reported 
that prevalence of gastric premalignant lesion increased 
with age. This condition was rare in individuals under 
the age of 40. While Malik et al. (2017) reported aging 
was not a risk factor for gastric premalignant lesion. The 
result of bivariate analysis of this study found a significant 
association between age and gastric premalignant lesion, but 
the association became insignificant through multivariate 
analysis. This suggests that age factor is not a significant 
risk factor for the occurrence of gastric premalignant lesion.
 The major ethnic group in this study was Batak 
(55.8%), since they inhabit most of North Sumatera region 
(Ambarsari et al. 2012). Batak was one of the ethnic in 
Indonesia with high rate of H. pylori infection (Syam et 
al. 2015). Batak ethnic has a habit of consuming alcohol 
both in traditional ceremony and daily life (Gaol & Husin 
2013). There was a significant association between ethnicity 
and gastric premaligant lesion from bivariate analysis and 
remained significant through multivariate analysis. The 
Batak ethnic increased risk of 1.69 times to experience 
gastric premalignant lesion (p=0.042). However, further 
study is needed to evaluate the high prevalence of gastric 
premalignant lesion in Batak ethnic. Background of genetic 
factors, nutritional factors or lifestyle, immune response to 
H. pylori infection may be considered. 
 The prevalence of H. pylori varies greatly between 
geographic areas related to personal and environmental 
hygiene. India, China, Turkey, the Dominican Republic 
and Brazil reported the prevalence of H. pylori infection 
were 65.9%, 44.92%, 65% 58.9%, 30.93%, respectively 
(Adlekha et al. 2013; Bilman et al. 2016; Li et al. 2016; 
Shiota et al. 2014; Trindade et al. 2017). There was a 
significant association between H. pylori infection and 
gastric premalignant lesion (p=0.003), where patients 
with H. pylori infection had a 4.63-fold risk of gastric 
premalignant lesion. Previous studies in Korea by Joo et al. 
(2013) and Kim et al. (2008) reported H. pylori is a major 
risk factor for both atrophic and intestinal metaplasia. H. 
pylori is a Type 1 carcinogen according to International 
Agency for Research on Cancer (IARC). H. pylori CagA (+) 
as well as interactions between peptidoglycans with host 
defense molecules will induce increased proinflammatory 
cytokines through NF-κβ activation. IL-8 which is one 
of proinflammatory cytokines is a chemoattractant for 
neutrophils and monocytes (Szoke 2009). Neutrophil 
infiltration of cellular lipid membranes will result in lipid 
peroxidation reactions that produce free radicals. Free 
radicals can interfere with tissue integrity, mediate mucosal 
injury by causing degradation of epithelial basement 
membrane, cell metabolic changes and DNA damage. 
The presence of reactive oxidative species and prolonged 
gastric inflammation leads to the progression of chronic 
gastritis to chronic atrophic gastritis (Tan & Yeoh 2015). In 
addition, H. pylori with CagA (+) will inject CagA proteins 
directly into the cell via type IV secretion system. The 
CagA protein will undergo tyrosine phosphorylation by Src 
family kinase. Tyrosine phosphorylated CagA will bind to 
Src homology 2 (SHP2) containing tyrosine phosphatase 
(SHP-2) protein. The CagA-SHP2 complex will inactivate the 
focal adhesion kinase (FAK) that causes cell morphological 
transformation. In addition, the CagA-SHP2 complex will 
induce an abnormal mitogenic signal through the Erk MAP 
kinase cascade that leads to carcinogenesis (Kusters et al. 
2006).
 A family history of gastric cancer remained 
independently associated with gastric cancer (Masjedizadeh 
et al. 2013; Shin et al. 2010). Meta-analysis study showed 
that first-degree relatives of patients with gastric cancer 
might be at an increased risk for developing gastric 
cancer (Rokkas et al. 2010). Relatives of patients with 
gastric cancer have an increased prevalence of gastric 
premalignant lesion (El-Omar et al. 2013). This study also 
found that patients with a family history of gastric cancer 
significantly increased risk to have gastric premalignant 
lesion. Pathophysiology remains unclear, may be due 
to the influence of genetic factors, the same exposure to 
carcinogens (nitrogen, cigarette smoke, alcohol) among 
family members, same diet (high salt, smoked), hygiene 
level and H. pylori infection.
 Effects of alcohol on gastric premalignant lesion 
are still controversial. This study found that alcohol 
significantly increased risk of having gastric premalignant 
lesion. Alcohol could cause some damage to gastric mucosa 
and induce chronic gastritis. In addition, alcohol could 
promote the absorption of carcinogen and decrease the 
detoxification activity of liver (Wu et al. 2013).
 Smoking is a risk factor for gastric cancer. Nicotine 
substances that mutagenic can bind to the gastric mucosal 
DNA. N-nitroso-compound present in tobacco plays a role 
in gastric carcinogenesis process (Nishino et al. 2006; 
Nomura et al. 2012). Felley et al. (2012) and Liu et al. 
(2010) reported that smoking was a risk factor for gastric 
premalignant lesion. While there is another study showed 
that smoking did not associated with gastric premalignant 
lesion (den Hoed et al. 2011). The difference in results 
might be due to differences in the frequency of smoking, 
duration of smoking and type of cigarettes commonly used. 
However, this study found that there were no associations 
between use of NSAIDs and high salt diet with gastric 
premalignant lesion.
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 Finally, this study had shown that only H. pylori 
infection, family history of gastric cancer, alcohol intake 
and ethnicity were the key factors to predict the individual 
chance of developing premalignant gastric lesion. 
Identifying individuals at risk is important in surveillance 
and prevention of gastric premalignant lesion and gastric 
cancer.
CONCLUSION
Risk factors of gastric premalignant lesion were H. pylori 
infection, family history of gastric cancer, alcohol intake 
and Batak ethnic. 
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